Taken together, the results indicate that targeting ZEB1 in tumor cells effectively inhibited recruitment and polarization of neutrophils, leading to activation of CD8+ T cells and a synergistic antitumor effect with chemoimmunotherapy in PC. This evidence concerns the gene CD8A and neoplasm.